Evidence map›Paper›PMID 38526387›Full record

ArticleAnesthesiology2024

Insurance-based Disparities in Outcomes and Extracorporeal Membrane Oxygenation Utilization for Hospitalized COVID-19 Patients.

Laurent G Glance, Karen E Joynt Maddox, Michael Mazzeffi, Ernie Shippey, Katherine L Wood, E Yoko Furuya, Patricia W Stone, Jingjing Shang, Isaac Y Wu, Igor Gosev and 5 more

Abstract read
In one paragraph

Article in Anesthesiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Saudi Guideline for Mechanical Ventilation in Adults.Saudi journal of medicine & medical sciences · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Laurent G GlanceDepartments of Anesthesiology and Perioperative Medicine and of Public Health Sciences, University of Rochester School of Medicine, Rochester, New York; and RAND Health, RAND, Boston, Massachusetts.ORCID 0000-0003-3381-699X
Karen E Joynt MaddoxDepartment of Medicine, Washington University in St. Louis, St. Louis, MO.; Center for Advancing Health Services, Policy & Economics Research, Institute for Public Health, Washington University in St. Louis, St. Louis, Missouri.
Michael MazzeffiDepartment of Anesthesiology, University of Virginia School of Medicine, Charlottesville, Virginia.
Ernie ShippeyVizient Center for Advanced Analytics, Chicago, Illinois.
Katherine L WoodDepartment of Surgery (Cardiac), University of Rochester School of Medicine, Rochester, New York.
E Yoko FuruyaDepartment of Medicine, Division of Infectious Diseases Columbia University Irving Medical Center, New York, New York.
Patricia W StoneColumbia University School of Nursing, Center for Health Policy, New York, New York.
Jingjing ShangColumbia University School of Nursing, Center for Health Policy, New York, New York.
Isaac Y WuDepartment of Anesthesiology and Perioperative Medicine, University of Rochester School of Medicine, Rochester, New York.
Igor GosevDepartment of Surgery (Cardiac), University of Rochester School of Medicine, Rochester, New York.
Stewart J LustikDepartment of Anesthesiology and Perioperative Medicine, University of Rochester School of Medicine, Rochester, New York.
Heather L LanderDepartment of Anesthesiology and Perioperative Medicine, University of Rochester School of Medicine, Rochester, New York.
Julie A WyrobekDepartment of Anesthesiology and Perioperative Medicine, University of Rochester School of Medicine, Rochester, New York.
Andres LasernaDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Palo Alto, California.
Andrew W DickRAND Health, RAND, Boston, Massachusetts.

Funding

Infection Prevention in Home Health Care (InHOME)R01NR016865 · NINR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SHANG, JINGJING, STONE, PATRICIA W. · 2017 to 2025
$6.4M
ImpAct of COVID-19 on CaRe TransitOns and Health OutcomeS for Vulnerable PopulationS in Nursing Homes and Home HealthCARE Agencies (ACROSS-CARE)R01AG074492 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SHANG, JINGJING, STONE, PATRICIA W. · 2021 to 2024
$3.2M
NIA NIH HHS R01 AG074492NINR NIH HHS R01 NR016865
6 · The paper itself

Abstract

backgroundThe objective of this study was to examine insurance-based disparities in mortality, nonhome discharges, and extracorporeal membrane oxygenation utilization in patients hospitalized with COVID-19.

methodsUsing a national database of U.S. academic medical centers and their affiliated hospitals, the risk-adjusted association between mortality, nonhome discharge, and extracorporeal membrane oxygenation utilization and (1) the type of insurance coverage (private insurance, Medicare, dual enrollment in Medicare and Medicaid, and no insurance) and (2) the weekly hospital COVID-19 burden (0 to 5.0%; 5.1 to 10%, 10.1 to 20%, 20.1 to 30%, and 30.1% and greater) was evaluated. Modeling was expanded to include an interaction between payer status and the weekly hospital COVID-19 burden to examine whether the lack of private insurance was associated with increases in disparities as the COVID-19 burden increased.

resultsAmong 760,846 patients hospitalized with COVID-19, 214,992 had private insurance, 318,624 had Medicare, 96,192 were dually enrolled in Medicare and Medicaid, 107,548 had Medicaid, and 23,560 had no insurance. Overall, 76,250 died, 211,702 had nonhome discharges, 75,703 were mechanically ventilated, and 2,642 underwent extracorporeal membrane oxygenation. The adjusted odds of death were higher in patients with Medicare (adjusted odds ratio, 1.28 [95% CI, 1.21 to 1.35]; P < 0.0005), dually enrolled (adjusted odds ratio, 1.39 [95% CI, 1.30 to 1.50]; P < 0.0005), Medicaid (adjusted odds ratio, 1.28 [95% CI, 1.20 to 1.36]; P < 0.0005), and no insurance (adjusted odds ratio, 1.43 [95% CI, 1.26 to 1.62]; P < 0.0005) compared to patients with private insurance. Patients with Medicare (adjusted odds ratio, 0.47; [95% CI, 0.39 to 0.58]; P < 0.0005), dually enrolled (adjusted odds ratio, 0.32 [95% CI, 0.24 to 0.43]; P < 0.0005), Medicaid (adjusted odds ratio, 0.70 [95% CI, 0.62 to 0.79]; P < 0.0005), and no insurance (adjusted odds ratio, 0.40 [95% CI, 0.29 to 0.56]; P < 0.001) were less likely to be placed on extracorporeal membrane oxygenation than patients with private insurance. Mortality, nonhome discharges, and extracorporeal membrane oxygenation utilization did not change significantly more in patients with private insurance compared to patients without private insurance as the COVID-19 burden increased.

conclusionsAmong patients with COVID-19, insurance-based disparities in mortality, nonhome discharges, and extracorporeal membrane oxygenation utilization were substantial, but these disparities did not increase as the hospital COVID-19 burden increased. EDITOR’S PERSPECTIVE:

Indexed as

COVID-19Extracorporeal Membrane OxygenationHealthcare DisparitiesMedicaidMedicareAdultAgedFemaleHospitalizationHospital MortalityHumansInsurance CoverageInsurance, HealthMaleMiddle AgedPatient Discharge

Identifiers

PMID38526387
PMCPMC11318453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.